Crossmark

Clinical differences between transthyretin cardiac amyloidosis and hypertensive heart disease

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.10.011

Published Print: 2024-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gallo-Fernández, Ignacio

López-Aguilera, José

González-Manzanares, Rafael

Pericet-Rodriguez, Cristina

Carmona-Rico, Manuel Jesús

Perea-Armijo, Jorge

Castillo-Domínguez, Juan Carlos

Anguita-Sánchez, Manuel
License Information

Text and Data Mining valid from 2024-03-01

stm-asf valid from 2024-03-01

stm-asf valid from 2024-03-01

stm-asf valid from 2024-03-01

stm-asf valid from 2024-03-01

stm-asf valid from 2024-03-01
More Information

This article is maintained by: Elsevier

Article Title: Clinical differences between transthyretin cardiac amyloidosis and hypertensive heart disease

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.10.011

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2023.10.006

Content Type: article

Copyright: © 2024 Published by Elsevier España, S.L.U.